Table 2. Blood indices at several key time points for Case 2.
| Time | Indices | Value |
|---|---|---|
| 2018-04-27 | WBC (109) | 7.14 |
| Neutrophils (109) | 5.33 | |
| Lymphocytes (109) | 1.02 | |
| Monocyte (109) | 0.73 | |
| RBC (109) | 3.94 | |
| Hemoglobin (g/L) | 109 | |
| Platelets (109) | 267 | |
| ALT (U/L) | 10 | |
| AST (U/L) | 14 | |
| ALP (U/L) | 82 | |
| TBIL (U/L) | 7.2 | |
| CYFRA21-1 (ng/mL) | 1.6 | |
| CEA (ng/mL) | <0.2 | |
| AFP (ng/mL) | 1.32 | |
| CA125 (ng/mL) | 12.49 | |
| CA153 (ng/mL) | 10.36 | |
| CA199 (ng/mL) | 5.1 | |
| SCC (ng/mL) | 0.5 | |
| NSE (ng/mL) | 7.34 | |
| 2020-05-16 | WBC (109) | 4.15 |
| Neutrophils (109) | 2.58 | |
| Lymphocytes (109) | 1.21 | |
| Monocyte (109) | 0.28 | |
| RBC (109) | 3.53 | |
| Hemoglobin (g/L) | 96 | |
| Platelets (109) | 209 | |
| ALT (U/L) | 8 | |
| AST (U/L) | 16 | |
| ALP (U/L) | 82 | |
| TBIL (U/L) | 2.8 | |
| 2020-06-05 | WBC (109) | 5.09 |
| Neutrophils (109) | 3.5 | |
| Lymphocytes (109) | 1.22 | |
| Monocyte (109) | 0.32 | |
| RBC (109) | 3.69 | |
| Hemoglobin (g/L) | 99 | |
| Platelets (109) | 244 | |
| ALT (U/L) | 7 | |
| AST (U/L) | 17 | |
| ALP (U/L) | 79 | |
| TBIL (U/L) | 3.8 | |
| 2020-06-23 | WBC (109) | 8.49 |
| Neutrophils (109) | 5.66 | |
| Lymphocytes (109) | 1.62 | |
| Monocyte (109) | 0.55 | |
| RBC (109) | 3.52 | |
| Hemoglobin (g/L) | 97 | |
| Platelets (109) | 440 | |
| ALT (U/L) | 9 | |
| AST (U/L) | 13 | |
| ALP (U/L) | 68 | |
| TBIL (U/L) | 4.3 |
WBC, white blood cell; RBC, red blood cell; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; TBIL, total bilirubin; CYFRA21-1, cytokeratin 19 fragment; CEA, carcinoembryonic antigen; AFP, alpha-fetoprotein; CA125, cancer antigen 125; CA153, cancer antigen 153; CA199, cancer antigen 199; SCC, squamous cell carcinoma; NSE, neuron-specific enolase.